Eye Drop

KOLOA, Hawaii — In this Healio Video Perspective from Hawaiian Eye 2025, Jason Bacharach, MD, of North Bay Eye Associates, discusses the benefits of Simple Drops from ImprimisRx for glaucoma.

KOLOA, Hawaii — In this Healio Video Perspective from Hawaiian Eye 2025, Paul Smith of Orasis Pharmaceuticals discusses the benefits that Qlosi provides patients with presbyopia.

Patients with presbyopia experienced improvements in near vision after treatment with Brimochol PF in a second phase 3 pivotal trial, according to a press release from Tenpoint Therapeutics.

CHICAGO — In this Healio Video Perspective from the AAO meeting, Arshad M. Khanani, MD, MA, FASRS, shares promising data from an ongoing phase 2/3 study investigating OCS-01, an eye drop for the treatment of diabetic macular edema.

Alcon Laboratories announced the voluntary recall of one lot of Systane Lubricant Eye Drops Ultra PF, Single Vials On-the-Go, following a consumer complaint that led to the discovery of fungal contamination in the drops.

In this Healio Video Perspective from the Tear Film & Ocular Surface Society meeting, Melissa Toyos, MD, FACS, discusses positive pharmacovigilance data for Lumify for the treatment of ocular redness.

Regener-Eyes has launched a new preservative-free, multidose bottle with an improved design to prevent backflow and avoid bacterial contamination, according to a company press release.

’Twas a time, not so very long ago, when eye doctors treating dry eye disease had heart-to-hearts about how we should discuss the latency between onset of treatment and when patients would finally begin to feel some relief.

CHICAGO — In this Healio Video Perspective from Eyecelerator@AAO, Paul Smith of Orasis Pharmaceuticals announces the closing of a $78 million financing round that will help the company move toward the launch of Qlosi for presbyopia.

Why are so many of our colleagues relying exclusively on eye drops to treat disease when more and more evidence shows how ineffective they are, particularly for surgical patients?